|
?:authorAffiliation
|
-
[\'The George Institute for Global Health; University of New South Wales, Sydney, New South Wales, Australia.\', \'Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.\', \'Department of Cellular and Molecular Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.\', \'School of Health and Life Sciences, Federation University Australia, Ballarat, Victoria, Australia.\', \'Imperial Clinical Trials Unit, Imperial College London, London, UK.\', \'Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia.\', \'Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.\', \'Third Department of Medicine, Hypertension Center STRIDE-7, School of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.\', \'Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester, Manchester, UK.\', \'CARIM-School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.\', \'Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, USA.\', \'Institute of Cardiovascular Science, University College London and National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK.\', \'The George Institute for Global Health; University of New South Wales, Sydney, New South Wales, Australia a.schutte@unsw.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}